We present a case of wild-type transthyretin cardiac amyloidosis incidentally discovered during two-vessel coronary artery bypass grafting (CABG) conducted for the resolution of diastolic congestive heart failure (CHF). This evidence concerns the gene TTR and cardiac amyloidosis.